A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery under General Anaesthesia (STARDOM2).

Next Previous
Trial Profile

A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery under General Anaesthesia (STARDOM2).

Recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2018

At a glance

  • Drugs Celecoxib/tramadol (Primary) ; Celecoxib; Tramadol
  • Indications Acute pain
  • Focus Registrational; Therapeutic Use
  • Acronyms STARDOM2
  • Sponsors Mundipharma Research

    • Most Recent Events

    • 06 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 08 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top